| Website | life-bond.com |
| Category | BioTech |
| Phone | 972-4-6373979 |
| Employees | |
| Description | Bio-Surgery Product Developer |
| Total | $28M |
| Series B, 6/09 Pitango Venture Capital Robert Taub | $8M |
| Series C, 5/11 Giza Venture Capital Aurum Ventures Pitango Venture Capital GlenRock Israel The Zitelman Group | $20M |
LifeBond is developing a line of products in bio-surgery. Specifically, the company is looking to develop a set of surgical sealants and hemostats intended for preventing leakage and bleeding. Proceeds from the most recent round of funding will be used for the completion of the pre-clinical and clinical phases of the Company’s initial product: LifeSeal SLR, a sealant indicated for reinforcement of gastro-intestinal anastomoses. Post-surgical leakage from anastomoses is currently a significant risk factor that can result in life threatening complications and costly re-operations. In certain surgical procedures the risk of leakage is up to 15% of overall procedures.
